These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27846059)

  • 1. Taurolidine in Pediatric Home Parenteral Nutrition Patients.
    Hulshof EC; Hanff LM; Olieman J; de Vette S; Driessen GJ; Meeussen C; Escher JC
    Pediatr Infect Dis J; 2017 Feb; 36(2):233-235. PubMed ID: 27846059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taurolidine lock - experience from the West of Scotland.
    Cullis PS; McKee RF
    Clin Nutr; 2011 Jun; 30(3):399-400; author reply 401. PubMed ID: 21256637
    [No Abstract]   [Full Text] [Related]  

  • 3. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial.
    Bisseling TM; Willems MC; Versleijen MW; Hendriks JC; Vissers RK; Wanten GJ
    Clin Nutr; 2010 Aug; 29(4):464-8. PubMed ID: 20061070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock.
    Chu HP; Brind J; Tomar R; Hill S
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):403-7. PubMed ID: 22595973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.
    Klek S; Szczepanek K; Hermanowicz A; Galas A
    JPEN J Parenter Enteral Nutr; 2015 Mar; 39(3):331-5. PubMed ID: 24604029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taurolidine locks significantly reduce the incidence of catheter-related blood stream infections in high-risk patients on home parenteral nutrition.
    Saunders J; Naghibi M; Leach Z; Parsons C; King A; Smith T; Stroud M
    Eur J Clin Nutr; 2015 Feb; 69(2):282-4. PubMed ID: 24642782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to Reduce Catheter-Related Bloodstream Infections in Pediatric Patients Receiving Home Parenteral Nutrition: The Efficacy of Taurolidine-Citrate Prophylactic-Locking.
    Lambe C; Poisson C; Talbotec C; Goulet O
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):1017-1025. PubMed ID: 29385236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition.
    Wouters Y; Theilla M; Singer P; Tribler S; Jeppesen PB; Pironi L; Vinter-Jensen L; Rasmussen HH; Rahman F; Wanten GJA
    Aliment Pharmacol Ther; 2018 Aug; 48(4):410-422. PubMed ID: 29978597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial.
    Tribler S; Brandt CF; Petersen AH; Petersen JH; Fuglsang KA; Staun M; Broebech P; Moser CE; Jeppesen PB
    Am J Clin Nutr; 2017 Sep; 106(3):839-848. PubMed ID: 28793993
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study.
    Wouters Y; Roosenboom B; Causevic E; Kievit W; Groenewoud H; Wanten GJA
    Clin Nutr; 2019 Oct; 38(5):2210-2218. PubMed ID: 30292482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections.
    Jurewitsch B; Lee T; Park J; Jeejeebhoy K
    JPEN J Parenter Enteral Nutr; 1998; 22(4):242-4. PubMed ID: 9661127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of taurolidine on the prevention of catheter-related bloodstream infections in patients on home parenteral nutrition.
    Al-Amin AH; Sarveswaran J; Wood JM; Burke DA; Donnellan CF
    J Vasc Access; 2013; 14(4):379-82. PubMed ID: 23817948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and economic impact of the taurolidine lock on home parenteral nutrition.
    Arnoriaga Rodríguez M; Pérez de Ciriza Cordeu M; Camblor Álvarez M; Bretón Lesmes I; Motilla de la Cámara M; Velasco Gimeno C; Arhip L; García Peris P; Cuerda Compés C
    Nutr Hosp; 2018 Jun; 35(4):761-766. PubMed ID: 30070861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do we know the benefits of a taurolidine lock in adult home parenteral nutrition patients with a low infection rate?
    Olthof ED; Broekman MM; Wanten GJ
    JPEN J Parenter Enteral Nutr; 2015 May; 39(4):385. PubMed ID: 25883235
    [No Abstract]   [Full Text] [Related]  

  • 15. Taurolidine lock: the key to prevention of recurrent catheter-related bloodstream infections.
    Jurewitsch B; Jeejeebhoy KN
    Clin Nutr; 2005 Jun; 24(3):462-5. PubMed ID: 15896434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter salvage or removal in catheter-related bloodstream infections with Staphylococcus aureus in children with chronic intestinal failure receiving home parenteral nutrition and the use of prophylactic taurolidine catheter lock solution: A descriptive cohort study.
    Demirok A; Illy DHC; Nagelkerke SQ; Lagerweij MF; Benninga MA; Tabbers MM
    JPEN J Parenter Enteral Nutr; 2024 May; 48(4):486-494. PubMed ID: 38605559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients.
    Koldehoff M; Zakrzewski JL
    Int J Antimicrob Agents; 2004 Nov; 24(5):491-5. PubMed ID: 15519483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Locks in Patients Receiving Home Parenteral Nutrition.
    Daoud DC; Wanten G; Joly F
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32050544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis.
    Solomon LR; Cheesbrough JS; Bhargava R; Mitsides N; Heap M; Green G; Diggle P
    Semin Dial; 2012; 25(2):233-8. PubMed ID: 21916999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to Olthof et al.
    Klek S; Szczepanek K
    JPEN J Parenter Enteral Nutr; 2015 May; 39(4):385-6. PubMed ID: 25883236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.